申请人:——
公开号:US20030100545A1
公开(公告)日:2003-05-29
Benzimidazolidinone derivative compounds, which increase acetylcholine signaling or effect in the brain, and highly selective muscarinic agonists, particularly for the M
1
and/or M
4
receptor subtypes, pharmaceutical compositions comprising the same, as well as methods of treating psychosis using these compounds are disclosed.
苯并咪唑啉酮衍生物化合物,可增加乙酰胆碱在大脑中的信号传导或作用,并且高度选择性的肌碱受体激动剂,特别是针对M1和/或M4受体亚型,还公开了包含这些化合物的药物组合物,以及使用这些化合物治疗精神病的方法。